Insider sale
TRANSPHORM TECHNOLOGY, INC.
$21.1K
7.88K shares
What this filing means
SMALES KELLY plans to sell 7.88K shares of TRANSPHORM TECHNOLOGY, INC. valued at approximately $21.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/24/2023ACC: 0001970051-23-000025
7.88K
Shares to sell
$21.1K
Approx. market value
4K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
COMMON STOCK
COMPENSATORY PAYMENT
10/11/2023
4KTotal acquired4K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/11/2023 | COMMON STOCK COMPENSATORY PAYMENT | 4K | — |
| Total | 4K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
656.00
Market value
$1.9K
11/20/2023
—Completed
Units to sell
3.23K
Market value
$8.8K
11/17/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
4K
Market value
$10.5K
11/22/2023
Total
Units
7.88K
Value
$21.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/20/2023 | 656.00 | $1.9K | — | Completed |
11/17/2023 | 3.23K | $8.8K | — | Completed |
| Planned — Approximate Date | ||||
11/22/2023 | 4K | $10.5K | NASDAQ | Planned |
| Total | 7.88K | $21.1K | ||